Jaumot Frank E
Known title: DirectorCIK: 0001303609
Jaumot Frank E's purchase track record
Jaumot Frank E has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/20/2026 | NUTX | $14K | +68.8% | +134.6% | +17.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| NUTX | ▲ Buy | Option Exercise | 603 | $0 | 7/31/2026 | View on chart |
| NUTX | ▲ Buy | Open Market | 150 | $14K | 3/20/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Nutex Health highlighted in recent healthcare stock roundups
Nutex Health appeared in a Seeking Alpha roundup of top healthcare stocks and in a Yahoo list of stocks to watch in October. The mentions place the company among peers that analysts consider noteworthy. This exposure comes while the stock trades near its recent support level.
Nutex Health highlighted in recent healthcare stock roundups. Nutex Health appeared in a Seeking Alpha roundup of top healthcare stocks and in a Yahoo list of stocks to watch in October. The mentions place the company among peers that analysts consider noteworthy. This exposure comes while the stock trades near its recent support level.